Health status of patients with Autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders (Belgium)
In December 2019 an outbreak of a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], previously 2019-nCoV) started in Wuhan, China, and has since become a global threat to human health1. In patients affected with this virus, 14 –53% cases reported abnormal levels of alanine aminotransferase and aspartate aminotransferase (AST) during disease progression1. Autoimmune hepatitis (AIH) is a rare autoimmune liver disease that is still poorly understood2. The cornerstone of treatment is the use of immunosuppressive drugs inclu ding azathioprine and corticosteroids.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Xavier Verhelst, Nicky Somers, Anja Geerts, Helena Degroote, Hans Van Vlierberghe Tags: Letter to the Editor Source Type: research
More News: Autoimmune Disease | Belgium Health | China Health | Coronavirus | Corticosteroid Therapy | COVID-19 | Gastroenterology | Hepatitis | Liver | Liver Disease | Outbreaks | Respiratory Medicine | SARS | Urology & Nephrology